MS
Maven Securities’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100,000
| Closed | -$190K | – | 297 |
|
|
2024
Q2 | $190K | Buy |
100,000
+75,000
| +300% | +$143K | ﹤0.01% | 266 |
|
|
2024
Q1 | $71K | Buy |
+25,000
| New | +$71K | ﹤0.01% | 296 |
|
|
2023
Q2 | – | Sell |
-100,000
| Closed | -$2.93M | – | 259 |
|
|
2023
Q1 | $2.93M | Sell |
100,000
-50,000
| -33% | -$1.47M | 0.06% | 49 |
|
|
2022
Q4 | $5.54M | Buy |
+150,000
| New | +$5.54M | 0.13% | 23 |
|